Lidet

Naproxen, the active ingredient in Lidet, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for systemic use. It is employed to relieve mild to moderate pain, reduce inflammation in musculoskeletal conditions, and lower fever in adult patients.

GNH USA supplies Lidet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality, regulatory compliance, and reliable logistics for global healthcare providers.

Naproxen acts systemically to alleviate pain and inflammation associated with several common conditions.

Mild to moderate pain: provides analgesic relief by decreasing pain perception. Osteoarthritis: reduces joint inflammation and improves mobility. Rheumatoid arthritis: helps control inflammatory activity and joint swelling. Fever: lowers elevated body temperature through antipyretic action.

Naproxen may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dyspepsia or upset stomach. - Nausea or vomiting. - Headache. - Dizziness. - Mild abdominal discomfort.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Acute renal impairment. - Cardiovascular events such as myocardial infarction. - Severe skin reactions (e.g., Stevens‑Johnson syndrome). - Hepatic dysfunction. - Anaphylactic reactions.

Before initiating therapy, consider patient‑specific factors and monitor for adverse events.

Assess renal function: avoid or adjust use in patients with significant renal impairment. Evaluate cardiovascular risk: use cautiously in individuals with a history of heart disease. Screen for gastrointestinal ulcer history: consider gastro‑protective measures if needed. Avoid concurrent use with other NSAIDs or anticoagulants unless medically justified. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Naproxen can interact with several drug classes, influencing safety and efficacy.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Selective serotonin reuptake inhibitors (SSRIs): heightened gastrointestinal bleeding. - ACE inhibitors or diuretics: potential reduction in renal function.

Moderate Interactions (Monitor Closely): - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Lithium: naproxen may raise lithium serum levels. - Methotrexate: possible decreased clearance leading to toxicity.